Blood and infection

Despite COVID-19, commitments to invest in the NHS must be honoured

January 2021 | By Alastair Whitington

The Westminster Health Forum, Key decisions for utilising NHS funding—priority areas, quality and delivery of care, the COVID-19 crisis, and long-term financial stability, was held […]

Restarting cancer services will require stratification and coordination

December 2020 | By Nina Buchan

As part of the Virtual UK Oncology Forum 2020, The Big COVID/Cancer Debate took place online on 25 September 2020. This fringe meeting, which was […]

Interview: Professor David Cunningham

December 2020 | By Alastair Whitington

In this short video, Professor David Cunningham, Consultant Medical Oncologist at the The Royal Marsden NHS Foundation Trust and Chair of the Association of Cancer […]

COVID-19 is an act of nature; the consequences are Government-made

December 2020 | By Alastair Whitington

As Britain’s health service faces the perfect storm of a second wave of COVID-19 amid winter pressures, how have the Government and the NHS performed […]

Rituximab and eculizumab for delayed haemolytic transfusion reactions: low-quality evidence, but a life‑threatening scenario

December 2020 | By Martin Bradley

In a recent commissioning policy, NHS England has commissioned eculizumab and rituximab for the management of delayed haemolytic transfusion reactions (DHTR) and hyperhaemolysis (HH), and rituximab […]

Hepatitis C elimination: learning from Greater Manchester

December 2020 | By Jeremy Hooper, James Roach, and Johnny Skillicorn-Aston

The approach to the elimination of disease-causing agents has undergone significant change over recent decades. The popular view of single-minded, lone scientists working in laboratories […]

Articles